Short Interest in INVO Bioscience, Inc. (NASDAQ:INVO) Expands By 10.0%

INVO Bioscience, Inc. (NASDAQ:INVO) saw a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 12,100 shares, an increase of 10.0% from the March 15th total of 11,000 shares. Based on an average daily trading volume, of 27,500 shares, the days-to-cover ratio is presently 0.4 days. Approximately 0.5% of the company’s stock are sold short.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the company. Armistice Capital LLC bought a new position in INVO Bioscience during the 1st quarter worth $882,000. Vanguard Group Inc. grew its holdings in shares of INVO Bioscience by 3.0% during the third quarter. Vanguard Group Inc. now owns 367,390 shares of the company’s stock worth $390,000 after purchasing an additional 10,653 shares during the last quarter. Sabby Management LLC bought a new stake in shares of INVO Bioscience during the third quarter worth about $183,000. UBS Group AG grew its holdings in shares of INVO Bioscience by 99,137.6% during the second quarter. UBS Group AG now owns 92,291 shares of the company’s stock worth $59,000 after purchasing an additional 92,198 shares during the last quarter. Finally, Virtu Financial LLC grew its holdings in shares of INVO Bioscience by 368.2% during the second quarter. Virtu Financial LLC now owns 50,555 shares of the company’s stock worth $33,000 after purchasing an additional 39,758 shares during the last quarter. Institutional investors own 12.02% of the company’s stock.

INVO Bioscience Trading Down 5.9 %

NASDAQ INVO opened at $0.77 on Tuesday. The company has a market cap of $1.89 million, a PE ratio of -0.06 and a beta of 1.45. The company has a current ratio of 0.37, a quick ratio of 0.31 and a debt-to-equity ratio of 2.94. INVO Bioscience has a 12 month low of $0.50 and a 12 month high of $10.96. The stock has a 50 day moving average of $1.00 and a 200-day moving average of $1.16.

About INVO Bioscience

INVO Bioscience, Inc, a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. INVO Bioscience, Inc was founded in 2007 and is based in Sarasota, Florida.